Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma tRCC
Study Type: Treatment
Phase: II
NCTID: NCT03595124
Principal Investigator:
Keith August
Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients with Renal Cell Carcinoma
A Phase III RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy PROSPER RCC
Study Type: Treatment
Phase: III
NCTID: NCT03055013
Principal Investigator:
Elizabeth Wulff-Burchfield
Phase III Randomized Trial of Stereotactic Ablative Radiotherapy SAbR for Oligometastatic Advanced Renal Carcinoma SOAR
Study Type: Treatment
Phase: III
NCTID: NCT05863351
Principal Investigator:
Elizabeth Wulff-Burchfield
Phase II Randomized Double Blind Trial of PF-04518600, an OX40 Antibody, in Combination with Axitinib versus Axitinib in Immune-Checkpoint Inhibitor Exposed Patients with Metastatic Renal Cell Carcinoma
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors DAWT and Relapsed Favorable Histology Wilms Tumors FHWT
Study Type: Treatment
Phase: II
NCTID: NCT04322318
Principal Investigator:
Keith August
Phase I/ II Trial of Pazopanib Alternating with Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma Patients
Outcomes Database to prospectivelY aSSEss the changing TherapY landscape in Renal Cell Carcinoma ODYSSEY RCC
Study Type: Treatment
Phase: IV
NCTID: NCT04919122
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase II Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies
A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis RadiCal
Study Type: Treatment
Phase: II
NCTID: NCT04071223
Principal Investigator:
Elizabeth Wulff-Burchfield